Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells.
about
Curcumin AntiCancer Studies in Pancreatic CancerCurcumin and tumor immune-editing: resurrecting the immune systemCurcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.Therapeutic applications of curcumin for patients with pancreatic cancer.Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.Curcumin: a potential candidate in prevention of cancer via modulation of molecular pathways.Curcumin-induced mitotic arrest is characterized by spindle abnormalities, defects in chromosomal congression and DNA damage.Mouse models of human T lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma.Emodin and DHA potently increase arsenic trioxide interferon-alpha-induced cell death of HTLV-I-transformed cells by generation of reactive oxygen species and inhibition of Akt and AP-1Biological and therapeutic activities, and anticancer properties of curcuminFucoxanthin enhances cisplatin-induced cytotoxicity via NFκB-mediated pathway and downregulates DNA repair gene expression in human hepatoma HepG2 cells.C1, a highly potent novel curcumin derivative, binds to tubulin, disrupts microtubule network and induces apoptosis.The state of the art in the pathogenesis of ATL and new potential targets associated with HTLV-1 and ATL.NF-kappaB in pathogenesis and treatment of adult T-cell leukemia/lymphoma.HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches.Anti cancer effects of curcumin: cycle of life and death.Curcumin analog cytotoxicity against breast cancer cells: exploitation of a redox-dependent mechanism.Targeting HTLV-1 activation of NFκB in mouse models and ATLL patients.Molecular mechanisms of curcumin action: gene expression.An overview of structure-activity relationship studies of curcumin analogs as antioxidant and anti-inflammatory agents.Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway.Delta-tocotrienol induces apoptotic cell death via depletion of intracellular squalene in ED40515 cells.Curcumin induces osteosarcoma MG63 cells apoptosis via ROS/Cyto-C/Caspase-3 pathway.Genistein induces apoptotic cell death associated with inhibition of the NF-κB pathway in adult T-cell leukemia cells.Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer.Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-kappaB activity.Soy-derived isoflavones inhibit the growth of adult T-cell leukemia cells in vitro and in vivo.Inhibition of constitutively active Jak-Stat pathway suppresses cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.Curcumin targets Akt cell survival signaling pathway in HTLV-I-infected T-cell lines.Retraction: Curcumin targets Akt cell survival signaling pathway in HTLV-I-infected T-cell lines.
P2860
Q26738714-EA70FE4C-5E6E-4393-AB0D-87300A2A743EQ26783491-607FC919-93D2-4E36-A1A2-89C91F674C03Q33906004-6ADE87B7-4CAC-4516-871A-93FFAFBD3B04Q33948351-53920D49-203A-4255-97A6-EF7F2269AED9Q34163076-18BAB9AF-9CEC-4AA8-A735-4C685EF28A9EQ34252516-F397237A-4D73-4B21-BD03-A9BB9F6A7DEDQ34466500-B632E975-B7E2-45E6-86F5-E0D1D44A0722Q35138158-B065A492-9BA5-4032-BD5C-593C330C5664Q35628873-347DD6CE-0CBF-4C87-B50D-3E058A9E3BBAQ36334519-B06F88B7-0D8E-46B4-8FB1-105DBFDBB271Q36586981-4A5635A6-4A92-4228-A9FF-6C855156A60BQ36842067-CFB3C340-6DD1-42E4-BA08-F58C80DCB08DQ37008645-4B09BA62-8A0F-44B5-9B13-B2067072DBDDQ37008647-F3FFCC93-52C2-4E63-A9E4-5672B75C4608Q37079191-A8630DA0-9112-4404-87E7-2F1B29E43FD0Q37286351-4418285D-1499-4282-9C22-D10F597C8B4FQ37470968-02C0F738-8703-40E3-9B5E-A8DBA15B6455Q37945228-A818104A-DE10-4BAC-9EF3-13D3FAC2EFC2Q38045211-C0A6BB59-4B82-4A3C-9688-410D6BC0A0D9Q38732481-084AFB08-6B55-42C8-8783-71A4572EA384Q38777239-1C2FD113-16F1-4054-A1A4-CDA3E0CF3E48Q38956158-CA2E673C-FBCE-40F6-8A01-38B4F66A2116Q39108043-63F2AFA6-11D6-4031-AA67-CDD18E134F76Q39176175-A49ED5B7-1156-49CC-9084-3E1FE58A18CBQ39677752-85EC7445-8641-4C30-9518-3359FFA2B6A9Q39802485-37BFD4B3-08B1-479D-A6DD-B64AAFAA5F21Q40087963-01F1C054-A7F5-4133-A447-697021DEFE26Q40294534-17FC39B6-0211-4B33-BFDD-8649410164A1Q53626403-85B31EE5-7469-4506-9F5C-B0C3D6C475C1Q55239272-FC5FBBCC-FFD7-41CC-BA0E-ACE03900E3B7
P2860
Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Curcumin (diferuloylmethane) i ...... y adult T-cell leukemia cells.
@en
Curcumin (diferuloylmethane) i ...... y adult T-cell leukemia cells.
@nl
type
label
Curcumin (diferuloylmethane) i ...... y adult T-cell leukemia cells.
@en
Curcumin (diferuloylmethane) i ...... y adult T-cell leukemia cells.
@nl
prefLabel
Curcumin (diferuloylmethane) i ...... y adult T-cell leukemia cells.
@en
Curcumin (diferuloylmethane) i ...... y adult T-cell leukemia cells.
@nl
P2093
P356
P1476
Curcumin (diferuloylmethane) i ...... y adult T-cell leukemia cells.
@en
P2093
Hirochika Kawakami
Jun-nosuke Uchihara
Kazuiku Ohshiro
Mariko Tomita
Masato Masuda
Naoki Mori
Nobuyuki Takasu
Taeko Okudaira
Takao Ohta
Takehiro Matsuda
P304
P356
10.1002/IJC.21389
P577
2006-02-01T00:00:00Z